N-Succinimidyl 3-Maleimidopropionate [Cross-linking Reagent]>98.0%(HPLC)(N)5g

TERT-BUTYL (2R,4S)-4-FLUORO-2-(HYDROXYMETHYL)PYRROLIDINE-1-CARBOXYLATE, 95.0%, 1g

(S)-2-(2,6,7,8-TETRAHYDRO-1H-INDENO[5,4-B]FURAN-8-YL)ETHANAMINE HCL, 97%, 1g

(5-Bromopyrazin-2-yl)methanol, 97%, 2.5g

(S)-2-Amino-2-(pyridin-4-yl)ethan-1-ol dihydrochloride, 95%, 1g

Cobalt(III) fluoride, 99.0%, 25g

[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate, 98.0%, 500g

(4,4-DIFLUORO-1-METHYLCYCLOHEXYL)METHANAMINE, 95.0%, 1g

Thalidomide-O-amido-C4-NH2 (TFA), 500mg

(4,6-Dichloropyridin-2-yl)methanol, 97.0%, 1g

N-(2-Hydroxyethyl)maleimide>98.0%(HPLC)(N)5g

Diammonium L-(+)-Tartrate>98.0%(T)100g

(R)-Benzyl 2-amino-3-(tert-butoxy)propanoate hydrochloride, 97.0%, 5g